Department of Health Management, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, PE, C1A 4P3, Canada.
Saskatchewan Health Quality Council, Atrium Building, Innovation Place, 241 - 111 Research Drive, Saskatoon, SK, S7N 3R2, Canada.
Can J Public Health. 2018 Dec;109(5-6):810-820. doi: 10.17269/s41997-018-0101-2. Epub 2018 Jun 28.
A small proportion of the population accounts for the majority of healthcare costs. Mental health and addiction (MHA) patients are consistently high-cost. We aimed to delineate factors amenable to public health action that may reduce high-cost use among a cohort of MHA clients in Saskatoon, Saskatchewan.
We conducted a population-based retrospective cohort study. Administrative health data from fiscal years (FY) 2009-2015, linked at the individual level, were analyzed (n = 129,932). The outcome of interest was ≥ 90th percentile of costs for each year under study ('persistent high-cost use'). Descriptive analyses were followed by logistic regression modelling; the latter excluded long-term care residents.
The average healthcare cost among study cohort members in FY 2009 was ~ $2300; for high-cost users it was ~ $19,000. Individuals with unstable housing and hospitalization(s) had increased risk of persistent high-cost use; both of these effects were more pronounced as comorbidities increased. Patients with schizophrenia, particularly those under 50 years old, had increased probability of persistent high-cost use. The probability of persistent high-cost use decreased with good connection to a primary care provider; this effect was more pronounced as the number of mental health conditions increased.
Despite constituting only 5% of the study cohort, persistent high-cost MHA clients (n = 6455) accounted for ~ 35% of total costs. Efforts to reduce high-cost use should focus on reduction of multimorbidity, connection to a primary care provider (particularly for those with more than one MHA), young patients with schizophrenia, and adequately addressing housing stability.
一小部分人口占据了大部分的医疗保健费用。精神健康和成瘾(MHA)患者的医疗费用一直居高不下。我们旨在确定可采取公共卫生措施的因素,以减少萨斯卡通萨斯喀彻温省的 MHA 患者队列中的高成本使用。
我们进行了一项基于人群的回顾性队列研究。对财政年度(FY)2009-2015 年的个人行政健康数据进行了分析(n=129932)。感兴趣的结果是每年成本的≥90%分位数(“持续高成本使用”)。进行描述性分析后,进行逻辑回归建模;后者排除了长期护理居民。
FY2009 研究队列成员的平均医疗保健费用约为 2300 美元;对于高成本使用者,约为 19000 美元。不稳定的住房和住院治疗的个体具有持续高成本使用的风险增加;随着合并症的增加,这两种影响更为明显。精神分裂症患者,尤其是年龄在 50 岁以下的患者,持续高成本使用的可能性增加。与初级保健提供者建立良好联系的患者,持续高成本使用的可能性降低;这种效果随着精神健康状况的增加而更加明显。
尽管仅占研究队列的 5%,但持续高成本的 MHA 患者(n=6455)占总费用的约 35%。减少高成本使用的努力应侧重于减少多种合并症,与初级保健提供者建立联系(特别是对于有多种 MHA 的患者),年轻的精神分裂症患者,并妥善解决住房稳定性问题。